How Latent Labs Plans To Create Medicines From Scratch With AI
Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for drug discovery and development ...
Therapeutic designer peptide to combat acute heart muscle weakness
Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...
C&EN1d
Designer peptides could save failed drug candidates
Short chains of amino acids can form drug delivery nanoparticles and boost the properties of potential medicines ...
Click chemistry method advances drug development with improved triazole synthesis
Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...
STAT1d
Two biotech companies claim they use AI to design drugs from scratch. Do they?
A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...